FdaApplication
NDA 022036
Identifiers
- fda_app_no: NDA022036
Properties
| Property | Value |
|---|---|
| applicant_name | CURRAX PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 2010-03-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SILENOR | DOXEPIN HYDROCHLORIDE | EQ 6MG BASE | TABLET;ORAL |
| SILENOR | DOXEPIN HYDROCHLORIDE | EQ 3MG BASE | TABLET;ORAL |
2 products